Leerink Partnrs Issues Negative Forecast for TVTX Earnings
Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) – Research analysts at Leerink Partnrs reduced their Q4 2025 earnings per share estimates for Travere Therapeutics in a report issued on Wednesday, June 11th. Leerink Partnrs analyst J. Schwartz now expects that the company will earn $0.13 per share for the quarter, down from their prior forecast […]
Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) – Research analysts at Leerink Partnrs reduced their Q4 2025 earnings per share estimates for Travere Therapeutics in a report issued on Wednesday, June 11th. Leerink Partnrs analyst J. Schwartz now expects that the company will earn $0.13 per share for the quarter, down from their prior forecast […]
